Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 4 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2019 Filed Mar 28, 2019 19:49 UTC |
Wood Michael BDirector
|
GrantCareer Restricted Stock Units · Derivative | 5,192 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021615 · doc4.xml · derivative · entry 10 Wood Michael B · CIK 0001306341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,192 Underlying: Ordinary Shares · 5,192 shares Expires not disclosed F10 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 5,192 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F10 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 5,192 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F10 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 5,192 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:49 UTC |
Wood Michael BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,495 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021615 · doc4.xml · derivative · entry 9 Wood Michael B · CIK 0001306341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,495 Underlying: Ordinary Shares · 3,495 shares Expires 2028-08-09 F9 · price: This option to purchase 3,495 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,495 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. F9 · derivative.exercise_date: This option to purchase 3,495 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,495 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:49 UTC |
Wood Michael BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,058 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021615 · doc4.xml · derivative · entry 8 Wood Michael B · CIK 0001306341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,058 Underlying: Ordinary Shares · 4,058 shares Expires 2027-08-09 F8 · price: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:49 UTC |
Wood Michael BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,781 | Not disclosed Strike: $71.40 | Not disclosed |
DisclosureSEC source: 0001209191-19-021615 · doc4.xml · derivative · entry 7 Wood Michael B · CIK 0001306341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,781 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 F7 · price: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:49 UTC |
Wood Michael BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,110 | Not disclosed Strike: $64.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-021615 · doc4.xml · derivative · entry 6 Wood Michael B · CIK 0001306341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,110 Underlying: Ordinary Shares · 4,110 shares Expires 2025-08-31 F6 · price: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:49 UTC |
Wood Michael BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,584 | Not disclosed Strike: $51.53 | Not disclosed |
DisclosureSEC source: 0001209191-19-021615 · doc4.xml · derivative · entry 5 Wood Michael B · CIK 0001306341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,584 Underlying: Ordinary Shares · 4,584 shares Expires 2024-08-06 F5 · price: This option to purchase 4,584 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,584 Old STERIS ordinary shares for $51.53 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option to purchase 4,584 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,584 Old STERIS ordinary shares for $51.53 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:49 UTC |
Wood Michael BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,218 | Not disclosed Strike: $32.36 | Not disclosed |
DisclosureSEC source: 0001209191-19-021615 · doc4.xml · derivative · entry 4 Wood Michael B · CIK 0001306341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 F4 · price: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:49 UTC |
Wood Michael BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,121 | Not disclosed Strike: $31.61 | Not disclosed |
DisclosureSEC source: 0001209191-19-021615 · doc4.xml · derivative · entry 3 Wood Michael B · CIK 0001306341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,121 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 F3 · price: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:49 UTC |
Wood Michael BDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,133 | Not disclosed Strike: $32.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021615 · doc4.xml · derivative · entry 2 Wood Michael B · CIK 0001306341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,133 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 F2 · price: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. F2 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:49 UTC |
Wood Michael BDirector
|
GrantOrdinary Shares | 22,331 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021615 · doc4.xml · nonDerivative · entry 1 Wood Michael B · CIK 0001306341 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,331 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:47 UTC |
WILSON LOYAL WDirector
|
GrantCareer Restricted Stock Units · Derivative | 13,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021614 · doc4.xml · derivative · entry 9 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,899 Underlying: Ordinary Shares · 13,899 shares Expires not disclosed F9 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,899 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F9 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,899 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F9 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 13,899 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:47 UTC |
WILSON LOYAL WDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,495 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021614 · doc4.xml · derivative · entry 8 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,495 Underlying: Ordinary Shares · 3,495 shares Expires 2028-08-09 F8 · price: This option to purchase 3,495 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,495 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option to purchase 3,495 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,495 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:47 UTC |
WILSON LOYAL WDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,058 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021614 · doc4.xml · derivative · entry 7 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,058 Underlying: Ordinary Shares · 4,058 shares Expires 2027-08-09 F7 · price: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:47 UTC |
WILSON LOYAL WDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,781 | Not disclosed Strike: $71.40 | Not disclosed |
DisclosureSEC source: 0001209191-19-021614 · doc4.xml · derivative · entry 6 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,781 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 F6 · price: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:47 UTC |
WILSON LOYAL WDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,110 | Not disclosed Strike: $64.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-021614 · doc4.xml · derivative · entry 5 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,110 Underlying: Ordinary Shares · 4,110 shares Expires 2025-08-31 F5 · price: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:47 UTC |
WILSON LOYAL WDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,218 | Not disclosed Strike: $32.36 | Not disclosed |
DisclosureSEC source: 0001209191-19-021614 · doc4.xml · derivative · entry 4 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 F4 · price: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:47 UTC |
WILSON LOYAL WDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,121 | Not disclosed Strike: $31.61 | Not disclosed |
DisclosureSEC source: 0001209191-19-021614 · doc4.xml · derivative · entry 3 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,121 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 F3 · price: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:47 UTC |
WILSON LOYAL WDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,133 | Not disclosed Strike: $32.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021614 · doc4.xml · derivative · entry 2 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,133 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 F2 · price: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. F2 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:47 UTC |
WILSON LOYAL WDirector
|
GrantOrdinary Shares | 29,156 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021614 · doc4.xml · nonDerivative · entry 1 WILSON LOYAL W · CIK 0001237389 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,156 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 46,664 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 8 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,664 Underlying: Ordinary Shares · 46,664 shares Expires 2028-05-31 F9 · price: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 46,664 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F9 · derivative.exercise_date: This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 46,664 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 32,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 7 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,000 Underlying: Ordinary Shares · 32,000 shares Expires 2027-05-30 F8 · price: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 32,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 32,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 30,000 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 6 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Ordinary Shares · 30,000 shares Expires 2026-06-01 F7 · price: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 30,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 30,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,000 | Not disclosed Strike: $67.98 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 5 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Ordinary Shares · 20,000 shares Expires 2025-08-10 F6 · price: This option becomes exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 20,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 20,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 28,000 | Not disclosed Strike: $53.52 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 4 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Ordinary Shares · 28,000 shares Expires 2024-05-30 F5 · price: This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option F5 · derivative.exercise_date: This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 22,000 | Not disclosed Strike: $45.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · derivative · entry 3 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,000 Underlying: Ordinary Shares · 22,000 shares Expires 2023-05-31 F4 · price: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantOrdinary Shares | 3,406 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · nonDerivative · entry 2 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 3,406 F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · ownership.nature: Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:46 UTC |
TOKICH MICHAEL JSr. Vice Pres., CFO
|
GrantOrdinary Shares | 50,458 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021612 · doc4.xml · nonDerivative · entry 1 TOKICH MICHAEL J · CIK 0001235611 · Sr. Vice Pres., CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,458 F1 · shares: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:44 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 2,872 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021611 · doc4.xml · derivative · entry 5 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,872 Underlying: Ordinary Shares · 2,872 shares Expires 2028-05-31 F6 · price: This option becomes exercisable as follows: 718 on May 31, 2019; 718 on June 1, 2020; 718 on June 1, 2021 and 718 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 2,872 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 718 on May 31, 2019; 718 on June 1, 2020; 718 on June 1, 2021 and 718 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 2,872 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:44 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 600 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021611 · doc4.xml · derivative · entry 4 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Ordinary Shares · 600 shares Expires 2027-05-30 F5 · price: This option becomes exercisable as follows: 150 on May 30, 2018; 150 on May 30, 2019; 150 on June 1, 2020 and 150 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 600 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 150 on May 30, 2018; 150 on May 30, 2019; 150 on June 1, 2020 and 150 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 600 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:44 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 596 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021611 · doc4.xml · derivative · entry 3 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 596 Underlying: Ordinary Shares · 596 shares Expires 2026-06-01 F4 · price: This option becomes exercisable as follows: 149 on June 1, 2017; 149 on June 1, 2018; 149 on June 3, 2019 and 149 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 596 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option becomes exercisable as follows: 149 on June 1, 2017; 149 on June 1, 2018; 149 on June 3, 2019 and 149 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 596 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:44 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantEmployee Stock Option (right to buy) · Derivative | 600 | Not disclosed Strike: $66.15 | Not disclosed |
DisclosureSEC source: 0001209191-19-021611 · doc4.xml · derivative · entry 2 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 Underlying: Ordinary Shares · 600 shares Expires 2025-05-28 F3 · price: This option becomes exercisable as follows: 150 on May 31, 2016, 150 on May 30, 2017, 150 on May 29, 2018 and 150 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 600 STERIS ordinary shares for $66.15 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option becomes exercisable as follows: 150 on May 31, 2016, 150 on May 30, 2017, 150 on May 29, 2018 and 150 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 600 STERIS ordinary shares for $66.15 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:44 UTC |
Tamaro RenatoV.P. & Corporate Treasurer
|
GrantOrdinary Shares | 4,251 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021611 · doc4.xml · nonDerivative · entry 1 Tamaro Renato · CIK 0001713987 · V.P. & Corporate Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,251 F1 · shares: 2,396 of these ordinary shares are restricted. The restrictions on the ordinary shares lapse as follows: 500 on May 28, 2019; 600 on October 1, 2019; 400 on June 1, 2020; 412 on June 1, 2021 and 484 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: 2,396 of these ordinary shares are restricted. The restrictions on the ordinary shares lapse as follows: 500 on May 28, 2019; 600 on October 1, 2019; 400 on June 1, 2020; 412 on June 1, 2021 and 484 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC |
Steeves Richard MartinDirector
|
GrantCareer Restricted Stock Units · Derivative | 3,593 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · derivative · entry 7 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,593 Underlying: Ordinary Shares · 3,593 shares Expires not disclosed F7 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F7 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,593 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC |
Steeves Richard MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 436 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · derivative · entry 6 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F6 · price: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option to purchase 436 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 436 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC |
Steeves Richard MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,058 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · derivative · entry 5 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,058 Underlying: Ordinary Shares · 4,058 shares Expires 2027-08-09 F5 · price: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC |
Steeves Richard MartinDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,781 | Not disclosed Strike: $71.40 | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · derivative · entry 4 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,781 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 F4 · price: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC |
Steeves Richard MartinDirector
|
GrantOrdinary Shares | 207,550 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · nonDerivative · entry 3 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 207,550 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F3 · ownership.nature: These ordinary shares are held by the reporting person's spouse. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC |
Steeves Richard MartinDirector
|
GrantOrdinary Shares | 319,557 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · nonDerivative · entry 2 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 319,557 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2 · ownership.nature: These ordinary shares are held in a trust. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:43 UTC |
Steeves Richard MartinDirector
|
GrantOrdinary Shares | 9,362 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021609 · doc4.xml · nonDerivative · entry 1 Steeves Richard Martin · CIK 0001657245 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,362 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantCareer Restricted Stock Units · Derivative | 688 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · derivative · entry 11 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 688 Underlying: Ordinary Shares · 688 shares Expires not disclosed F11 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 688 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F11 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 688 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F11 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 688 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,893 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · derivative · entry 10 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,893 Underlying: Ordinary Shares · 4,893 shares Expires 2028-08-09 F10 · price: This option to purchase 4,893 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,893 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. F10 · derivative.exercise_date: This option to purchase 4,893 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,893 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,058 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · derivative · entry 9 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,058 Underlying: Ordinary Shares · 4,058 shares Expires 2027-08-09 F9 · price: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. F9 · derivative.exercise_date: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,781 | Not disclosed Strike: $71.40 | Not disclosed |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · derivative · entry 8 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,781 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 F8 · price: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. F8 · derivative.exercise_date: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 4,110 | Not disclosed Strike: $64.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · derivative · entry 7 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,110 Underlying: Ordinary Shares · 4,110 shares Expires 2025-08-31 F7 · price: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. F7 · derivative.exercise_date: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 2,037 | Not disclosed Strike: $51.53 | Not disclosed |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · derivative · entry 6 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,037 Underlying: Ordinary Shares · 2,037 shares Expires 2024-08-06 F6 · price: This option to purchase 2,037 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 2,037 Old STERIS ordinary shares for $51.53 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option to purchase 2,037 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 2,037 Old STERIS ordinary shares for $51.53 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 2,069 | Not disclosed Strike: $43.92 | Not disclosed |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · derivative · entry 5 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,069 Underlying: Ordinary Shares · 2,069 shares Expires 2023-08-08 F5 · price: This option to purchase 2,069 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 2,069 Old STERIS ordinary shares for $43.92 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option to purchase 2,069 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 2,069 Old STERIS ordinary shares for $43.92 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,218 | Not disclosed Strike: $32.36 | Not disclosed |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · derivative · entry 4 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,218 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 F4 · price: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,121 | Not disclosed Strike: $31.61 | Not disclosed |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · derivative · entry 3 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,121 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 F3 · price: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantDirector Stock Option (right to buy) · Derivative | 3,133 | Not disclosed Strike: $32.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · derivative · entry 2 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,133 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 F2 · price: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. F2 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:42 UTC |
Sohi MohsenDirector
|
GrantOrdinary Shares | 22,361 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021608 · doc4.xml · nonDerivative · entry 1 Sohi Mohsen · CIK 0001293588 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,361 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.